The purified Ig(B12) was conjugated with MMAE using a protease-cleavable valine-citruline linker with a carbonyl acrylic acid head-group. In brief, inter-chain disulfide bonds of a full-length IgG(B12) were reduced using excess amounts of DTT and reacted with 60 equivalents of carbonylacrylic acid-valine citruline-MMAE molecule(25 (link)). The reaction was stirred at 37° C for 8-10hrs. The antibody-drug conjugate was then purified using a desalting column and concentrated using Vivaspin devices (GE Healthcare). The average drug-to-antibody ratio was 4:1 as determined by native mass-spectrometry.